Ubiquitin C-terminal hydrolase-L1 potentiates cancer chemosensitivity by stabilizing NOXA

Cell Reports

Volumn 3, Issue 3, 2013, Pages 881-891

  Brinkmann, Kerstin ^a,b   Zigrino, Paola ^a   Witt, Axel ^a,b   Schell, Michael ^b   Ackermann, Leena ^b   Broxtermann, Pia ^a,b   Schüll, Stephan ^a,b   Andree, Maria ^a,b   Coutelle, Oliver ^a,b   Yazdanpanah, Benjamin ^a   Seeger, Jens Michael ^a,b   Klubertz, Daniela ^a,b   Drebber, Uta ^a   Hacker, Ulrich T ^a   Krönke, Martin ^a,b   Mauch, Cornelia ^a   Hoppe, Thorsten ^b   Kashkar, Hamid ^a,b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; CISPLATIN; DOXORUBICIN; ETOPOSIDE; LYSINE; POLYUBIQUITIN; PROTEIN NOXA; UBIQUITIN THIOLESTERASE;

ANIMAL CELL; ARTICLE; CAENORHABDITIS ELEGANS; CANCER CELL; CHEMOSENSITIVITY; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN METABOLISM; PROTEIN PROCESSING; PROTEIN STABILITY;

CAENORHABDITIS ELEGANS;

EID: 84875808231     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.02.014     Document Type: Article

References (39)

1. Acs K., Luijsterburg M.S., Ackermann L., Salomons F.A., Hoppe T., Dantuma N.P. The AAA-ATPase VCP/p97 promotes 53BP1 recruitment by removing L3MBTL1 from DNA double-strand breaks. Nat. Struct. Mol. Biol. 2011, 18:1345-1350.
2. Baou M., Kohlhaas S.L., Butterworth M., Vogler M., Dinsdale D., Walewska R., Majid A., Eldering E., Dyer M.J., Cohen G.M. Role of NOXA and its ubiquitination in proteasome inhibitor-induced apoptosis in chronic lymphocytic leukemia cells. Haematologica 2010, 95:1510-1518.
3. Bonazzi V.F., Nancarrow D.J., Stark M.S., Moser R.J., Boyle G.M., Aoude L.G., Schmidt C., Hayward N.K. Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma. PLoS One 2011, 6:e26121.
4. Boudreaux D.A., Maiti T.K., Davies C.W., Das C. Ubiquitin vinyl methyl ester binding orients the misaligned active site of the ubiquitin hydrolase UCHL1 into productive conformation. Proc. Natl. Acad. Sci. USA 2010, 107:9117-9122.
5. Conradt B., Horvitz H.R. The C. elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9. Cell 1998, 93:519-529.
6. Eldridge A.G., O'Brien T. Therapeutic strategies within the ubiquitin proteasome system. Cell Death Differ. 2010, 17:4-13.
7. Elgendy M., Sheridan C., Brumatti G., Martin S.J. Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival. Mol. Cell 2011, 42:23-35.
8. Gartner A., Milstein S., Ahmed S., Hodgkin J., Hengartner M.O. A conserved checkpoint pathway mediates DNA damage--induced apoptosis and cell cycle arrest in C. elegans. Mol. Cell 2000, 5:435-443.
9. Giacomini P., Aguzzi A., Ferrone S. Differential susceptibility to modulation by recombinant immune interferon of HLA-DR and -DQ antigens synthesized by melanoma COLO 38 cells. Hybridoma 1986, 5:277-288.
10. Gumienny T.L., Lambie E., Hartwieg E., Horvitz H.R., Hengartner M.O. Genetic control of programmed cell death in the Caenorhabditis elegans hermaphrodite germline. Development 1999, 126:1011-1022.
11. Henderson M.J., Vij N., Zeitlin P.L. Ubiquitin C-terminal hydrolase-L1 protects cystic fibrosis transmembrane conductance regulator from early stages of proteasomal degradation. J. Biol. Chem. 2010, 285:11314-11325.
12. Hoeller D., Dikic I. Targeting the ubiquitin system in cancer therapy. Nature 2009, 458:438-444.
13. Kashkar H., Krönke M., Jürgensmeier J.M. Defective Bax activation in Hodgkin B-cell lines confers resistance to staurosporine-induced apoptosis. Cell Death Differ. 2002, 9:750-757.
14. Kashkar H., Haefs C., Shin H., Hamilton-Dutoit S.J., Salvesen G.S., Kronke M., Jurgensmeier J.M. XIAP-mediated caspase inhibition in Hodgkin''s lymphoma-derived B cells. J. Exp. Med. 2003, 198:341-347.
15. Kashkar H., Deggerich A., Seeger J.M., Yazdanpanah B., Wiegmann K., Haubert D., Pongratz C., Krönke M. NF-kappaB-independent down-regulation of XIAP by bortezomib sensitizes HL B cells against cytotoxic drugs. Blood 2007, 109:3982-3988.
16. Komander D., Clague M.J., Urbé S. Breaking the chains: structure and function of the deubiquitinases. Nat. Rev. Mol. Cell Biol. 2009, 10:550-563.
17. Larsen C.N., Price J.S., Wilkinson K.D. Substrate binding and catalysis by ubiquitin C-terminal hydrolases: identification of two active site residues. Biochemistry 1996, 35:6735-6744.
18. Larsen C.N., Krantz B.A., Wilkinson K.D. Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases. Biochemistry 1998, 37:3358-3368.
19. Liu Y., Fallon L., Lashuel H.A., Liu Z., Lansbury P.T. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson''s disease susceptibility. Cell 2002, 111:209-218.
20. Liu Y., Lashuel H.A., Choi S., Xing X., Case A., Ni J., Yeh L.A., Cuny G.D., Stein R.L., Lansbury P.T. Discovery of inhibitors that elucidate the role of UCH-L1 activity in the H1299 lung cancer cell line. Chem. Biol. 2003, 10:837-846.
21. Oda E., Ohki R., Murasawa H., Nemoto J., Shibue T., Yamashita T., Tokino T., Taniguchi T., Tanaka N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000, 288:1053-1058.
22. Orlowski R.Z., Kuhn D.J. Proteasome inhibitors in cancer therapy: lessons from the first decade. Clin. Cancer Res. 2008, 14:1649-1657.
23. Ploner C., Kofler R., Villunger A. Noxa: at the tip of the balance between life and death. Oncogene 2008, 27(Suppl 1):S84-S92.
24. Ross A.J., Li M., Yu B., Gao M.X., Derry W.B. The EEL-1 ubiquitin ligase promotes DNA damage-induced germ cell apoptosis in C. elegans. Cell Death Differ. 2011, 18:1140-1149.
25. Sato N., Fukushima N., Maitra A., Matsubayashi H., Yeo C.J., Cameron J.L., Hruban R.H., Goggins M. Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res. 2003, 63:3735-3742.
26. Schmidt P., Kopecky C., Hombach A., Zigrino P., Mauch C., Abken H. Eradication of melanomas by targeted elimination of a minor subset of tumor cells. Proc. Natl. Acad. Sci. USA 2011, 108:2474-2479.
27. Schwickart M., Huang X., Lill J.R., Liu J., Ferrando R., French D.M., Maecker H., O'Rourke K., Bazan F., Eastham-Anderson J., et al. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature 2010, 463:103-107.
28. Seeger J.M., Schmidt P., Brinkmann K., Hombach A.A., Coutelle O., Zigrino P., Wagner-Stippich D., Mauch C., Abken H., Krönke M., Kashkar H. The proteasome inhibitor bortezomib sensitizes melanoma cells toward adoptive CTL attack. Cancer Res. 2010, 70:1825-1834.
29. Shibue T., Suzuki S., Okamoto H., Yoshida H., Ohba Y., Takaoka A., Taniguchi T. Differential contribution of Puma and Noxa in dual regulation of p53-mediated apoptotic pathways. EMBO J. 2006, 25:4952-4962.
30. Stergiou L., Hengartner M.O. Death and more: DNA damage response pathways in the nematode C. elegans. Cell Death Differ. 2004, 11:21-28.
31. Timmons L., Court D.L., Fire A. Ingestion of bacterially expressed dsRNAs can produce specific and potent genetic interference in Caenorhabditis elegans. Gene 2001, 263:103-112.
32. Villunger A., Michalak E.M., Coultas L., Müllauer F., Böck G., Ausserlechner M.J., Adams J.M., Strasser A. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 2003, 302:1036-1038.
33. Vucic D., Dixit V.M., Wertz I.E. Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death. Nat. Rev. Mol. Cell Biol. 2011, 12:439-452.
34. Wertz I.E., Kusam S., Lam C., Okamoto T., Sandoval W., Anderson D.J., Helgason E., Ernst J.A., Eby M., Liu J., et al. Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature 2011, 471:110-114.
35. Wilkinson K.D., Lee K.M., Deshpande S., Duerksen-Hughes P., Boss J.M., Pohl J. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 1989, 246:670-673.
36. Youle R.J., Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 2008, 9:47-59.
37. Yu J., Tao Q., Cheung K.F., Jin H., Poon F.F., Wang X., Li H., Cheng Y.Y., Röcken C., Ebert M.P., et al. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors. Hepatology 2008, 48:508-518.
38. Zhong Q., Gao W., Du F., Wang X. Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 2005, 121:1085-1095.
39. Zigrino P., Mauch C., Fox J.W., Nischt R. Adam-9 expression and regulation in human skin melanoma and melanoma cell lines. Int. J. Cancer 2005, 116:853-859.